Destiny Pharma’s AMR Paper

Monday November 21, 2022

It is AMR Awareness Week!  The World Health Organisation has declared that Anti-Microbial Resistance (AMR) is one of the top 10 global public health threats facing humanity.  Destiny Pharma is developing novel anti-infectives, with a focus on infection prevention, to address the global challenge of AMR.  Read our AMR paper here.